Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Debt / NOTE 2.250% 5/1
-
Market price (% of par)
-
131.32%
-
Total 13F principal
-
$375,623,000
-
Principal change
-
-$863,000
-
Total reported market value
-
$494,220,208
-
Number of holders
-
42
-
Value change
-
-$875,957
-
Number of buys
-
10
-
Number of sells
-
17
Institutional Holders of NEUROCRINE BIOSCIENCES INC - NOTE 2.250% 5/1 as of Q1 2022
As of 31 Mar 2022,
NEUROCRINE BIOSCIENCES INC - NOTE 2.250% 5/1 was held by
42 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$375,623,000
in principal (par value) of the bond.
The largest 10 bondholders included
FRANKLIN RESOURCES INC, TENOR CAPITAL MANAGEMENT Co., L.P., D. E. Shaw & Co., Inc., MACKAY SHIELDS LLC, WELLS FARGO & COMPANY/MN, Weiss Asset Management LP, Invesco Ltd., CSS LLC/IL, Davidson Kempner Capital Management LP, and WOLVERINE ASSET MANAGEMENT LLC.
This page lists
42
institutional bondholders reporting positions
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.